Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

Early ENT Manifestations in Eosinophilic Granulomatosis with Poliangioitis: Results from Our Cohort Group and Literature Review

Version 1 : Received: 15 September 2023 / Approved: 19 September 2023 / Online: 20 September 2023 (07:36:05 CEST)

A peer-reviewed article of this Preprint also exists.

D’Onofrio, M.; La Prova, D.; Galdiero, M.R.; Cantone, E.; Tremante, E.; Mascolo, M.; Barbieri, V.; Di Nola, C.; Spadaro, G.; de Paulis, A.; Detoraki, A. Early Ear, Nose and Throat Manifestations in Eosinophilic Granulomatosis with Poliangioitis: Results from Our Cohort Group and Literature Review. J. Clin. Med. 2023, 12, 6967. D’Onofrio, M.; La Prova, D.; Galdiero, M.R.; Cantone, E.; Tremante, E.; Mascolo, M.; Barbieri, V.; Di Nola, C.; Spadaro, G.; de Paulis, A.; Detoraki, A. Early Ear, Nose and Throat Manifestations in Eosinophilic Granulomatosis with Poliangioitis: Results from Our Cohort Group and Literature Review. J. Clin. Med. 2023, 12, 6967.

Abstract

Eosinophilic Granulomatosis with Polyangiitis (EGPA) is a rare systemic necrotizing vasculitis, affecting small-to-medium sized vessels. EGPA’s clinical manifestations are heterogeneous affecting different organs and systems and the upper respiratory tract can be affected with Ear, Nose and Throat (ENT) involvement. The aim of our study was to assess type manifestations at time of diagnosis in a cohort of EGPA patients and correlate findings with baseline variables (sex, age, antineutrophil cytoplasmic antibodies –ANCA- status) and literature reports. Main ENT manifestations in our patients at time of diagnosis were: nasal polyposis (CRSwNP) (52%), turbinate hypertrophy (48%), nasal swelling (40%), rhinorrhoea (40%), chronic rhinosinusitis without nasal polyposis (CRSsNP) (32%), nasal bone deformities (32%), nasal crusts (20%), nasal mucosal ulcers (12%), corditis (12%), hoarseness/dysphonia (12%), hearing loss (12%), mucoceles(4%) eosinophilic rhinitis (4%). No correlations were found between sex, age, ANCA status and ENT clinical manifestations. A polymorphic ENT involvement is often observed at early stages of EGPA. The presence of nasal, sinus, ear and/or laryngeal manifestations in patients with asthma and hypereosinophilia, independently of sex, age or ANCA status, should raise allert for further investigation and differential diagnosis for EGPA. ENT specialists should be aware of their leading position in this diagnostic race.

Keywords

eosinophilic granulomatosis with polyangiitis; EGPA; ENT; rhinosinusitis; CRSwNP; hearing loss; otitis; ANCA; vasculitis

Subject

Medicine and Pharmacology, Immunology and Allergy

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.